NRAS mutation in a central conducting lymphatic anomaly and PPFIBP1::ROS1 fusion in a Gorham-stout disease patient
Human Molecular Genetics · 2026
DOI: 10.1093/hmg/ddag070 ↗Kurz gefasst
Fallbericht in der Zeitschrift Human Molecular Genetics, 2026. Verfasst von Guangxian Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Surgery, The Affiliated Children's Hospital of Xiangya School of Medicine (Hunan Children's Hospital), Central South University, 86 Zi…. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, GTP Phosphohydrolases, Lymphatic Abnormalities, Membrane Proteins. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation.
Abstract (Originalsprache)
Lymphatic malformations (LMs) can lead to severe clinical complications, including disfigurement and even death. While genomic alterations have been identified in LMs, the genomic landscape of complex LMs remains poorly defined due to their rarity. In this study, we report two novel findings: an NRAS p.Q61R mutation in central conducting lymphatic anomaly (CCLA) and a PPFIBP1::ROS1 fusion in Gorham–Stout disease (GSD), both described for the first time in their respective LM subtypes. The discovery of the PPFIBP1::ROS1 fusion provided a unique opportunity to localize the somatic event to a specific cell type. Using serial tissue sections from the same specimen, we observed that the fusion signal was spatially associated with lymphatic endothelial cells, based on serial section analysis with D2–40 staining. Given that both NRAS mutations and PPFIBP1::ROS1 fusions have also been identified in other LM subtypes, our findings support the hypothesis that LMs may share common molecular mechanisms. We propose that phenotypic diversity among LM subtypes may arise from differences in developmental timing, anatomic location, and microenvironmental context at the time the somatic mutation occurs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiothoracic Surgery, The Affiliated Children's Hospital of Xiangya School of Medicine (Hunan Children's Hospital), Central South University, 86 Ziyuan Road, Yuhua District, Changsha, Hunan 410007, China.
- Advanced Molecular Pathology Institute of Soochow University and SANO, No. 218 Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu 215123, China.
- Suzhou SANO Precision Medicine Ltd, SANO Medical Laboratories, No. 288 Qiyue Street, Suzhou Industrial Park, Suzhou, Jiangsu 215123, China.
- Department of Pathology, The Affiliated Children's Hospital of Xiangya School of Medicine (Hunan Children's Hospital), Central South University, 86 Ziyuan Road, Yuhua District, Changsha, Hunan 410007, China.
- Department of Radiology, The Affiliated Children's Hospital of Xiangya School of Medicine (Hunan Children's Hospital), Central South University, 86 Ziyuan Road, Yuhua District, Changsha, Hunan 410007, China.
- Hematology Ward 2; Clinical Nursing Teaching and Research Section, The Second XiangYa Hospital of Central South University, No. 139 Middle Renmin Road, Furong District, Changsha, Hunan 410011, China.
ORCID-Profile: Sheng Xiao
Förderung
- Hunan Provincial Natural Science Foundation
Zitieren
APA
Yang, G., Ren, H., Wang, J., Chen, W., Li, X., Chen, S., Chen, H., Zhao, L., Fan, W., & Xiao, S. (2026). NRAS mutation in a central conducting lymphatic anomaly and PPFIBP1::ROS1 fusion in a Gorham-stout disease patient. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddag070
Vancouver
Yang G, Ren H, Wang J, Chen W, Li X, Chen S, et al. NRAS mutation in a central conducting lymphatic anomaly and PPFIBP1::ROS1 fusion in a Gorham-stout disease patient. Human Molecular Genetics. 2026. doi:10.1093/hmg/ddag070
BibTeX
@article{Yang2026,
author = {Yang, Guangxian and Ren, Haoran and Wang, Jinghua and Chen, Weijian and Li, Xiaoming and Chen, Si and Chen, Huafei and Zhao, Lina and Fan, Wenwen and Xiao, Sheng},
title = {NRAS mutation in a central conducting lymphatic anomaly and PPFIBP1::ROS1 fusion in a Gorham-stout disease patient},
journal = {Human Molecular Genetics},
year = {2026},
doi = {10.1093/hmg/ddag070}
}
EUVIMED